Skip to main content
. 2012 Jul 12;11:44. doi: 10.1186/1475-2840-11-44

Figure 1.

Figure 1

The design of the DCCT-EDIC study and the development of late complications (From Nat Rev Endocrinol 2010; 6:665–675, with permission of the publisher [Nature Publishing Group]). RET: retinopathy, ALB: albuminuria, NEU: neuropathy, mALB: microalbuminuria, HYP: hypertension, CVD: cardiovascular diseases.